For more information on our recent data notice, please click here

Menu
Search

Coronavirus-Related News from UC San Diego Health

3/22/2023
UC San Diego researchers describe why SARS-CoV-2 subvariants spread more rapidly than the original virus strain, and how an early treatment might have made people more susceptible to future infections ...
10/31/2022
UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive ...
8/10/2022
A UC San Diego-led program that monitors wastewater for the presence of SARS-CoV-2 and which has effectively predicted subsequent surges in COVID-19 cases in San Diego has been expanded to detect the ...
6/21/2022
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
6/15/2022
A UC San Diego study describes the short- and long-term neurological symptoms of SARS-CoV-2 infection, and identifies a new group of COVID-19 long-haulers with advanced motor and cognitive symptoms.
4/6/2022
UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adu ...
3/21/2022
UC San Diego Health is now administering Evusheld to eligible, immunocompromised patients to protect against the COVID-19 virus.
2/28/2022
New York Times

​Features Joel Wertheim, PhD

2/28/2022
STAT

​Features UC San Diego School of Medicine

2/28/2022
San Diego Union Tribune

​Features Howard Taras, MD

2/28/2022
KPBS

​Features Lucy Horton, MD, MPH

2/23/2022
San Diego Union Tribune

​Features Jess Mandel, MD

12/10/2021
Few places in the country are better equipped to detect new virus variants than San Diego, where researchers at UC San Diego School of Medicine and Scripps Research, working with county public health ...

​For the Media

Contacts for Journalists

COVID-19 Media Statements

Related Content